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“I just always loved science. As far back as I can remember, I knew I would be
a medical doctor working in science. I immersed myself in science in elementary and high school, participating, for example, in science fairs, which, in Canada, are structured a little differently than in ‘the States.’ I did a lot of work on
my own; my projects were quite homemade, performed, for the most part, in
my basement. There was no formal collaboration with any particular outside
vendor, though my parents were supportive, even if I made a big mess of
their house; one of the highlights was that I got to go to the Canada-Wide
Science Fair, which, for a student working out of their basement, was exciting.
I got to travel and met other students with a similar passion, learning what
they did and what inspired them.”

P

erhaps it is not surprising that an already legendary career of clinical excellence,
unparalleled medical microbiology research contributions, and service to the
microbiology and infectious diseases communities may very well have germinated from
this grade school basement mad scientist. Robin Patel, M.D., the Elizabeth P. and Robert
E. Allen professor of individualized medicine, professor of microbiology, and professor
of medicine at the Mayo Clinic in Rochester, Minnesota, is the subject of this biographical feature. She is recognized and lauded as a pioneer, mentor, and leader in the ﬁeld
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of clinical microbiology. Peter H. Gilligan, Ph.D. (1), currently adjunct professor of
pathology–laboratory medicine at the University of North Carolina School of Medicine,
succinctly summarized Patel’s status in the ﬁeld of clinical and medical microbiology,
“Dr. Patel is probably the single most accomplished person that I know in the ﬁeld of
clinical microbiology.” Richard B. (Tom) Thomson, Jr., Ph.D. (2), medical microbiologist
from NorthShore University Healthcare in Evanston, Illinois, added, “There are natural
leaders in our profession from and with whom we all seek out to learn and collaborate.
Robin is one of these. She is a preeminent scientist that I follow and seek collaboration
with to improve my understanding of clinical microbiology.” In a recent interview with
Patel, the phrase “make a difference” was uttered with high frequency; what follows is
an attempt to chronicle how Robin Patel has made a difference in clinical microbiology
and its afﬁliated disciplines.
Robin Patel was born in Winnipeg, Manitoba, Canada. She and her family moved to
the suburbs of Montreal, Québec, when she was four years old, and she is a product of
the public-school system. She was educated in “French immersion” in an Englishspeaking school during most of her schooling. Patel noted that secondary education in
Québec is different than that in the United States, in that high school runs from the
seventh grade through the eleventh grade. In many circumstances, individuals who
plan to attend a university matriculate in a two-year Collège d’enseignement general et
professionnel (CEGEP) program (3) following high school. Patel’s completion of a year in
a CEGEP program at Marianapolis College in Montreal facilitated her completion of
baccalaureate studies (with magna cum laude honors) at Princeton University in three
years. She remarked, “I didn’t come from a wealthy background, and Princeton was a
little pricey, so I thought it was a good idea to hurry up my education; I’m not sure I
would have made that decision today.” Patel majored in chemistry and described how
Princeton mandated a junior year project as well as an undergraduate senior thesis.
Patel used laboratory (chemistry) research to fulﬁll these requirements. She chuckled, “I
loved working in the laboratory, doing independent work; I had a lot of fun with that.
I am certain that I did not make a major contribution to science at that time, but I did
learn a lot. Princeton provided unique opportunities that would shape my research
career.”
Patel returned to Canada for medical school, entering McGill University in Montreal
on a full scholarship. Her intention was to complete postgraduate training in the United
States and then return to Canada to practice. Those plans obviously changed upon her
ultimate decision of training location. She recollected, “I interviewed at a number of
places on the East Coast and in the Midwest. I didn’t have a lot of resources, so I applied
to places within driving distance. [Mayo Clinic] was a different interview than those I
had experienced at any of the other places that I looked at, and that was what made
up my mind; there was a distinct focus.” Mayo Clinic has been characterized by some
(2, 4) as being rather unique for its patient-centered philosophy, even with respect to
diagnostic and basic science paradigms. One past doctoral student of Patel (whose
professional afﬁliation restricted them from going on record but hereby is gratefully
acknowledged for their contribution to this biographical feature) related that the
unique opportunity of rounding with Patel (on transplant infectious diseases) was
experienced on multiple occasions. One thing that was learned from observing Patel in
this role was the belief that (hospitalized) patients were most often the best source of
information for what was going on with their cases; Patel essentially instilled the fact
that directly asking at the source is generally the most efﬁcient approach.
Patel decided upon internal medicine residency training at Mayo Clinic because it
allowed the opportunity to “dive deep” into other areas of medicine (one of which was
infectious diseases, for which she completed fellowship training at Mayo Clinic in 1995).
Again, because her original intention was to return to Canada, and because in Canada
(Québec, in particular) many infectious diseases practitioners are also clinical microbiologists (similar to the British system), she decided to additionally complete a clinical
microbiology fellowship (by way of an American Board of Pathology training program)
at Mayo Clinic in 1996. In the end, Patel learned that she “absolutely loved clinical
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microbiology. Clinical microbiology seemed like the perfect area where I could work in
science and medical practice, making a difference with laboratory science and bringing
research to the table as well. That experience would forever change my career.”
Patel was already engaged in nondedicated research time during residency training
and published nearly two dozen manuscripts prior to her ﬁrst academic appointment
at Mayo Clinic in 1996. Her research career began to explode during her infectious
diseases fellowship under the tutelage of Carlos Paya, M.D. Dr. Paya was a virologist by
trade, and Patel “cut her teeth” on cytomegalovirus (5, 6). Patel recalled, “It was the
early 1990s when the ﬁeld of transplant infectious diseases was being birthed. Mayo
Clinic was one of the ﬁrst places to have a formal clinical transplant infectious diseases
program; the opportunity to study infectious diseases in this patient population was
unprecedented. Much of what we know to be true today was in the process of being
learned back then. [Dr. Paya] was a natural person for me to work with and to train me
in laboratory-based but, at the same time, translational research; this molded my
career.” This notes one early example of a paradigm that has been consistent throughout Patel’s career: applying skills as a basic scientist to clinical needs in the ﬁeld.
With Mayo Clinic being one of the early leaders in transplant infectious diseases, it
also was one of the ﬁrst clinical locations to recognize the importance of vancomycinresistant Enterococcus spp. (VRE) in transplant populations (7). Patel recollected, “We
were able to track the ﬁrst introduction and spread of VRE into our health care
institution, in addition to understanding VRE therapeutics, all because of our transplant
program, which is where I had cut my teeth in translational research.” As a result, she
was instrumental in developing assays to detect vancomycin resistance in these
organisms, described a new vancomycin resistance gene in enterococci (8), and deﬁned
a homolog to vancomycin resistance genes in enterococci in the biopesticide Paenibacillus popilliae (9). Patel concluded, “For me, it started off as just another type of
infection affecting the patients I was seeing (the transplant patients) and then became
a really interesting scientiﬁc area.”
Upon full-time faculty appointment, Patel assumed directorship of the infectious
diseases research laboratory at Mayo Clinic, largely on account of a desire of her
collaborator, Dr. James Steckelberg, to return to clinical practice. She continued a
strong collaboration with Dr. Steckelberg relative to his long-standing interests in bone
and joint infections (10) and endocarditis (11). Bone and joint infection research was of
heightened interest because Mayo Clinic had introduced an orthopedic infectious
diseases clinical service to complement a large orthopedic surgery referral service. As
time progressed, the frequency of arthroplasty procedures increased, and the entity of
periprosthetic joint infection had become commonplace. In the words of Patel, colleagues approached her claiming that this was “essentially a new disease, but we are
using the same diagnostics that we had been using for native joint infection. We have
gaps in this ﬁeld, and we think that someone like you, who is trained in clinical
microbiology and translational research, could help come up with better ways of
diagnosing and treating periprosthetic and other orthopedic implant-associated infections.”
At the same juncture, Patel’s research laboratory was busy characterizing medical
bioﬁlms, relative to organisms including Staphylococcus lugdunensis (12), Candida
albicans, and Pseudomonas aeruginosa. Patel then reasoned (with growing exuberance
in her voice), “Wow, if we take the understanding of bioﬁlms that is coming from
environmental microbiology—more so than medical microbiology—and put that together with what is happening with orthopedic implant-associated infections, I think
we stand a chance of being better to understand what is going on and probably to
come up with better diagnostics and therapeutics. So, I listened to my colleagues, and
I reasoned, ‘I think this is a ﬁeld that needs improvement; I am going to try to make a
difference.’” The convergence of these events resulted in, according to Shawn Vasoo,
MBBS, MRCP (clinical director, head of infectious diseases research laboratory, National
Centre for Infectious Diseases, Singapore), “seminal work on bioﬁlm-associated infections, particularly sonication of prosthetic orthopedic devices for infections (13) and in
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further deﬁning how these should be applied clinically.” Elitza S. Theel, Ph.D., director,
infectious diseases serology laboratory at Mayo Clinic, concurred, “Dr. Patel’s most
inﬂuential work has really revolved around improving diagnostics for prosthetic joint
infections. This includes both her innovative work around sonication of explanted
prosthetic joints to increase the recovery of bacteria and, more recently, the application
of metagenomics for identiﬁcation of the more difﬁcult-to-detect pathogens.”
Patel also chairs the Division of Clinical Microbiology in the Department of Laboratory Medicine and Pathology at Mayo Clinic. Thomas F. Smith, Ph.D. (4), emeritus chair
of the Division of Clinical Microbiology at Mayo Clinic, wrote, “Dr. Patel is an iconic
physician who, as chair of the Division of Clinical Microbiology, leads a very talented
group of microbiologists. She encourages their development by her independent skills
of outstanding writing and appreciation of collaboration with clinical colleagues (she
also appreciates the connective and translative role of a clinical microbiologist with the
practice of medicine) and focus on an extremely strong work ethic.” Alexander J.
McAdam, M.D., Ph.D., current editor in chief of Journal of Clinical Microbiology, wrote
that Patel is able to recognize and implement promising new methods very quickly.
“She was among the ﬁrst in the United States to see the potential of matrix-assisted
laser desorption ionization–time of ﬂight mass spectrometry for microbiology (14) and
was a leader for introducing this method into clinical use.”
Not to be lost in the realm of clinical microbiology and translational research is the
potential contribution of the bench technologist. Patel opined, “Bench technologists
can become better bench technologists by desiring to become better bench technologists, by being interested in what they are doing, and by asking probing questions.
Questioning and having an open eye can make a difference.” She noted that important
ﬁndings and changes in laboratories can emanate not only from the laboratory director
but also from a bench technologist. Patel then related a story of how one esoteric plate
ﬁnding from a bench technologist translated into a multicenter investigation that
linked high serum levels of ammonia in lung transplant recipients with Ureaplasma
infection, rendering an often-fatal disease curable (15). She additionally offered her
opinion that clinical microbiology is in the midst of a massive technology revolution. As
a result, some testing may leave the physical microbiology laboratory for other clinical
settings, such as at the point of care. With that, she warned, “There remains a need for
our medical science expertise; we should lead the science” and followed up by
remarking that “we’re able to do so many things today that we could never do 10 or
15 years ago. Our practice will continue to change; it is just so exciting to think about
how we’re going to increasingly make a difference in patient care.”
Commitment to clinical and translational research is further exempliﬁed by more
than 450 peer-reviewed publications, a larger number of abstracts, and nearly two
dozen book chapters. She is also listed on two United States patents related to her work
on bioﬁlms as well as a direct detection method for Bordetella spp. Patel’s laboratory
currently has stewardship or costewardship over 9 federal grants or subawards, 12
industry grants, and 4 institutional awards. She has been bestowed with numerous
honors, including fellowship in the American Academy of Microbiology in 2012, the BD
Award for Research in Clinical Microbiology in 2015, and the Mayo Medical School
Distinguished Service Award.
Patel has fulﬁlled a second major component of the academic triad, namely,
teaching, in robust fashion. When asked to comment about Patel, Dr. Gilligan cited her
directorship of the medical microbiology course at the Mayo Clinic Alix School of
Medicine. “She gets people excited about clinical microbiology. I, myself, have learned
much about teaching from her.” Patel ﬁrst taught in the course as a fellow and has
directed this course since 2001. She shared, “I love to teach. In medical science, there
is a culture of education. We always have trainees, and we are always teaching the next
generation; at the same time, I learn so much from the students. I particularly enjoy
working with students who are learning something for the ﬁrst time or in a new way
and will take that knowledge and apply it in the world and probably advance it at the
same time.” Advancements in technology have altered the means of medical student
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education over the years; Patel largely sees herself nowadays in the role of a facilitator
or tour guide. “Different learners prefer to learn in different ways, and that comes back
to the tour guide analogy; we just need to make sure everybody on the tour is staying
with the program and learning what they’re supposed to be learning. It is ﬁne if each
learner gets there in slightly different ways.”
Patel’s commitment to teaching extends into mentorship. Her provided curriculum
vitae lists 14 pages’ worth of students who have worked or completed projects in her
research laboratory. Her curriculum vitae itemizes papers (which number in the dozens)
in which the primary author was a Patel mentee. She summarized her research
mentorship philosophy as such: “In my research laboratory, there’s a culture of having
people from all over the world train as part of our laboratory team. We have had
laboratory members—I call them laboratory family members—from Asia, Australia,
Latin America, Europe, Canada (anywhere, really). I have Ph.D. students, medical
students, postdocs, and so forth; for me, it’s a natural way of doing research—we do
research, we train people to do research, and we all learn together, leveraging my
experience from the past, to move in a good direction together. A key component of
my research team is the three research technologists, Kerryl Greenwood-Quaintance,
Melissa Karau, and Suzannah Schmidt-Malan, who have been part of my team for 25,
15, and 10 years, respectively.”
The previously mentioned doctoral trainee of Patel related the experience of how,
for a Ph.D. student (rather than a medical student or fellow), an extended-duration and
more substantive research project would have to be devised. Patel conceived a new,
appropriately sized project seemingly overnight. Bobbi S. Pritt, M.D., director, clinical
parasitology laboratory at Mayo Clinic, and an editor for the Journal of Clinical Microbiology, was also a clinical microbiology fellowship trainee at Mayo. She wrote, “Right
from the start, Dr. Patel challenged me to think independently and use the results of my
own literature review and analysis of the data to answer clinical questions.” Patel’s
accommodating style is conducive to these relationships. Dr. Vasoo commented,
“Despite being very busy, I was personally very touched by how she always made time
for her fellows. We would meet weekly, one on one, and it would be dedicated time for
us to discuss issues with research or with training, to ask questions, and to catch up.
That’s been something which has profoundly inﬂuenced me and how I relate to and
mentor trainees.” Dr. Theel added that during her one-on-one fellowship interview with
Patel, “I remember being amazed at how focused she was on me and on what I was
saying, despite her pager buzzing, her phone ringing, and her email inbox ﬁlling. I
realized then that she is the type of individual who, once dedicated to something, does
not get easily distracted and sees it through to completion.”
Patel segued into a third pillar of the academic triad (service) by opining, “When
you’re at your institution running your laboratory and things are going well, you look
for other ways to contribute to the ﬁeld (and learn at the same time), such as serving
the government, societies, and other groups.” She is director of the National Institutes
of Health (NIH) Laboratory Center for the NIH’s Antibacterial Resistance Leadership
Group (16) and an advisor to the Clinical and Laboratory Standards Institute Subcommittee on Antimicrobial Susceptibility Testing (17). She is also a past chair of the U.S.
Medical Licensing Examination Microbiology and Immunology Test Material Development Committee. Patel served as an associate editor for Journal of Clinical Microbiology
from 2009 to 2019, currently serves as an associate editor for Clinical Infectious Diseases,
has served as an editorial board member for Clinical Microbiology Reviews and Antimicrobial Agents and Chemotherapy, and is a volume editor for the 12th edition of Manual
of Clinical Microbiology.
With all of that said, perhaps Patel’s most renowned contributions to professional
societies (particularly the American Society for Microbiology [ASM]) have been in the
form of leadership. Dr. Thomson wrote, “Robin has been instrumental in establishing
the sound scientiﬁc focus of clinical microbiology . . . as a chair of many professional
committees, she easily solicits broad participation, ensures accomplishment of all tasks,
and is appreciative of everyone’s efforts.” One of Patel’s ﬁrst major ASM leadership
September 2020 Volume 58 Issue 9 e01259-20
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contributions involved her two stints on the Interscience Conference on Antimicrobial
Agents and Chemotherapy (ICAAC) Program Committee (from 2002 to 2007 and from
2012 to 2015). She recalled, “I had a fantastic time programming their meeting and
loved meeting the other members of the program committee and hearing about what
they saw as important new areas in the ﬁeld of infectious diseases and microbiology.
Learning how to program a meeting, how to handle abstract review, and generally how
to put together a meeting on behalf of a society was so rewarding. This was a fantastic
way to volunteer my time. I was able to give back to something that was previously
given to me.” Dr. Gilligan remarked that of all of the activities in which he has
participated with ASM, “I got the most pleasure working with ICAAC because of
working with Robin Patel. We were teammates; she wasn’t the boss.”
When the decision was made to merge the ICAAC and the ASM General Meeting,
Patel and several microbiologists formed the ASM Microbe 2016 Steering Committee.
Following service on the ASM board of directors from 2017 to 2018, Patel was asked to
run for the ofﬁce of ASM president. She is completing her one-year term at the time of
this writing and described the role that a president serves within this scientiﬁc society:
“The president attempts to represent the over 30,000 members of the American Society
for Microbiology—this is impossible to do without a glitch, obviously; it has been a big
learning experience for me! You’re not representing yourself, you’re representing the
society and its members and yet trying to speak with one ‘ASM’ voice to the public, to
other scientiﬁc societies, and also, of course, to the membership of ASM. ASM is such
a large society and is so diverse that representing everyone and everything ASM does
and represents is challenging. There are so many different types of microbiologists
involved; but this is also ASM’s strength.”
Patel remarked that becoming ASM president made her realize and understand how
much work the society does, some of which may be unbeknownst to many. She cited
one program as an example. Milestones in Microbiology recognizes locations or speciﬁc
sites that have made historic contributions to the ﬁeld of microbiology (https://lib
.guides.umbc.edu/c.php?g⫽836720&p⫽6543681#s-lg-box-wrapper-26527244). As ASM
president, Patel dedicated two new sites during her term, one of which was the Saranac
Laboratory (subsequently assimilated into the Trudeau Institute in 1964) in upstate New
York for their work on Mycobacterium tuberculosis. Again, with great zeal, she commented, “For ASM to recognize these sites is so important; if microbiologists don’t
recognize microbiologists and microbiology, no one else will. At Saranac Lake in
particular, this dedication wasn’t just for the microbiologists but for the general public
that lived there, many of whom didn’t appreciate the importance of the science that
had happened there; this was the ﬁrst facility in the United States built speciﬁcally for
research on tuberculosis. While they did understand the importance of the sanatorium
and the tuberculosis patients and their treatment, the dedication highlighted its
importance to the ﬁeld of microbiology. For example, decades of research conducted
there led to the ﬁnding that both M. tuberculosis and the environment contribute to the
development of tuberculosis. This site is of enormous importance for microbiology; it
was my pleasure to be able to help recognize it.” Patel also traveled to several ASM
branch meetings during her presidency. With further enthusiasm, she commented,
“Wow, I was just so impressed with what goes on locally. There is so much depth and
richness at the branch level, with many branches having a particularly large contingent
of students. I’ve learned that ASM touches so many at so many levels. I have been
impressed with the way a society can bring people together and elevate microbiology
for the scientists and the communities in which we live.”
One of Patel’s current research interests is worldwide antimicrobial resistance in
general and, speciﬁcally, the role of laboratory diagnostics in mitigating spread of
resistance (18). She reasoned, “Part of the problem is that we just haven’t had good
diagnostics. This has bred a culture of empiricism in terms of antibiotic usage, with
many infectious diseases being treated based on a laying of the hands on a patient,
with a history and physical, a pronouncement of a clinical diagnosis, and a prescription
for an antibiotic. Today, we can do this much more precisely, better using our precious
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antibiotics and better caring for our fellow humans; I think this is just going to continue
to improve.” Patel has used her platform as ASM president within the past year to
broadcast a similar message. She participated in global events hosted around the
United Nations General Assembly and the World Health Organization as an ASM
representative.
An obvious recent paradigm in which Patel’s leadership has been sought as ASM
president is the SARS-CoV-2 infection pandemic. When assuming the ofﬁce of president, Patel intimated that she recognized that “there’s always a possibility that a global
health crisis happens during the year one is president.” Patel used her ofﬁce as an
opportunity to educate media, to speak to the United States government in a nonpartisan fashion, and to advocate for microbiologists on behalf of the society (augmenting
the long-standing role of ASM in this regard).
Stefano Bertuzzi, Ph.D., chief executive ofﬁcer of ASM, commented about the
complementary role of a president within a scientiﬁc society: “Essentially, the role of the
CEO is that of running the society, and that of president as chair of the board is to
ensure that the organization is run well and provide constructive input when course
correction is needed. I think that Dr. Patel has understood and embodied these
concepts perfectly.” To that end, “Robin is also a visionary person. She understands the
ﬁeld of clinical microbiology of today. She has a vision for what clinical microbiology
needs to be tomorrow, and this is invaluable as ASM president; she does not tinker with
minutiae. She is a big-picture person with a vision.” Dr. Bertuzzi further commented that
ASM was fortunate to have a world subject matter expert as its president during the
SARS-CoV-2 infection pandemic (19). “Never before has the mission of ASM come more
into focus . . . I could not be more thankful to Dr. Patel and her colleagues for the service
not only to ASM but to the global community at a perilous moment.”
The obvious question that arises in the minds of many is, how does all of this get
accomplished? The expression “woman with superpowers” was mentioned by approximately one-third of interviewees. One noted immaculate time management skills,
resulting in the completion of more work in one day than what most people can
complete in one week (or two). Dr. Gilligan hypothesized that if one were to do a
Google image search for “multitasker,” Robin Patel’s likeness would show up. Patel’s
humble and matter-of-fact retort to the same question was, “I almost always work in
teams, rarely doing anything alone. It’s by working together that we get things done.”
She also thanked her husband, Norbert, and their two children, David and Michelle, for
their unwavering support of her career. Colleague-described attributes such as “approachable and inclusive,” “cheerful and optimistic,” “terribly smart/brilliant,” “very
observant,” “photographic memory,” “energetic,” “keen sense of humor,” “laughs a lot,”
“an eye for detail,” “great communicator,” and “self-effacing—she doesn’t have to be
the smartest person in the room” likely also contribute to Patel’s overall success in and
impact on the ﬁeld.
To conclude, besides the general realm of science motivating Dr. Robin Patel along
her career path, one also returns to the patient-centered experience as a motivating
factor. She explained, “When you know that what you are doing could potentially make
someone’s life better or save a life, that’s highly motivating. We can see it—small but
incremental ﬁndings that make a difference. We’ve done things and found things that
have clearly changed people’s lives or even saved them. That sounds pretentious, I
know, but it’s true, and there is just nothing more fulﬁlling or motivating than that. Of
course, that type of thing doesn’t happen every day; it’s a process to get there, but you
don’t arrive unless you start.”
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